What is the recommended technique for transrectal ultrasound‑guided placement of three gold fiducial markers in the prostate before definitive radiotherapy, including needle gauge, anesthesia, antibiotic prophylaxis, and post‑procedure imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Gold Fiducial Marker Placement for Prostate Radiotherapy

Gold fiducial markers should be placed transrectally under ultrasound guidance using 18-gauge needles, with prophylactic antibiotics, without mandatory local anesthesia, and confirmed by post-procedure CT imaging. 1

Technique Overview

The EAU-EANM-ESTRO-ESUR guidelines establish that image-guided radiotherapy (IGRT) using gold markers or cone-beam CT is the standard approach for dose-escalated IMRT, as organ movement is critical for both tumor control and minimizing toxicity 1. This technique achieves severe late toxicity rates of only 2-4% for rectum and 2-6% for genitourinary tract 1.

Specific Technical Parameters

Number and Placement of Markers

  • Three gold fiducial markers is the standard configuration 2, 3
  • Markers should be strategically positioned to allow visualization and correction of organ movement in real-time 1
  • Critical aspects include identifying appropriate implantation locations, ensuring adequate spacing between markers, and confirming the needle bevel is completely within the gland before deployment 3

Needle Gauge

While the evidence shows successful placement with various gauges, 18-gauge needles are commonly used for standard gold seed markers 3, 4. Newer flexible notched wire markers (Gold Anchor) require 22-gauge needles 5, though these may adopt irregular shapes requiring more sophisticated tracking.

Anesthesia

Local anesthesia is not mandatory. A 2021 study of 46 patients demonstrated that transrectal fiducial placement without local anesthesia resulted in 80% of patients reporting pain levels lower than their prostate biopsy, with 35% reporting no pain at all (level 0) 6. Only mild adverse events (Grade 1) occurred in 20% of patients, with no Grade 2 or higher complications 6.

Antibiotic Prophylaxis

Prophylactic antibiotic therapy is recommended 7. In a series of 169 patients receiving prophylactic antibiotics, only 2 patients (1.18%) developed urinary tract infections, both with organisms resistant to the prophylactic regimen 7. Without adequate prophylaxis, infection rates can be problematic, particularly with the transrectal approach 8.

Pre-Procedure Preparation

  • Fleet enema before the procedure 7
  • Review anticoagulation status and consider temporary interruption if appropriate 7

Post-Procedure Imaging

CT imaging should be performed after marker placement to confirm correct positioning 4. In one series, this confirmed proper placement of 297 of 300 markers (99%), identifying 2 markers just outside the capsule and 1 lost marker 4.

Safety Profile and Complications

The procedure demonstrates excellent safety across multiple large series:

  • Technical success rate: 99-100% 2, 3, 4
  • Infection rate: 0.14-1.3% with prophylactic antibiotics 3, 4, 7
  • Marker migration: 0.32% 7
  • No grade 3 or higher complications in most series 2, 7, 6

Minor complications include:

  • Self-limiting rectal/intraprostatic hemorrhage (4%) 4
  • Mild dysuria, hematuria, or urinary frequency (6-20%) 6
  • Rectal bleeding (4%) 6

Important Caveat

Complications occur more frequently in patients with high tumor grade (Gleason score) and should prompt heightened vigilance 4.

Transperineal vs. Transrectal Approach

A 2024 meta-analysis of 13 studies found that transperineal placement significantly reduces urinary tract infections and rectal bleeding compared to transrectal 8. However, the transrectal approach remains widely used and safe when performed with proper technique and antibiotic prophylaxis, with very low absolute complication rates 3, 7.

The transrectal approach under ultrasound guidance is well-established, requires no special positioning beyond standard lithotomy, and can be performed efficiently in an outpatient setting 2, 3.

Procedural Workflow

  1. Administer prophylactic antibiotics
  2. Perform fleet enema
  3. Position patient for transrectal ultrasound access
  4. Use endocavitary ultrasound probe with biopsy trajectory visualization software
  5. Deploy 3 markers with adequate spacing using proper needle orientation
  6. Obtain post-procedure CT to confirm marker position
  7. Allow appropriate interval (typically days to 1-2 weeks) before initiating radiotherapy 4

Clinical Context

This procedure enables daily on-line image guidance adjustments during IMRT, which is essential for the dose-escalated techniques (typically 75.6-79.2 Gy) that have become standard for prostate cancer 1, 2. The markers facilitate real-time visualization and correction of prostate position, directly impacting both tumor control and toxicity outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.